-
Mashup Score: 5JNCCN - 21 day(s) ago
JNCCN
Source: jnccn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2JNCCN 360 - Breast - Australian Study Investigates Who May Safely Omit Postoperative Radiotherapy for Early Breast Cancer - 26 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2JNCCN 360 - Breast - Study Identifies Novel Therapeutic Targets for Males With Breast Cancer - 26 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2JNCCN 360 - Advanced Skin Cancers - Anti–PD-L1 Refractory Melanoma: Combining Tyrosine Kinase and PD-1 Inhibitors - 26 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0JNCCN 360 - Prostate - More FORMULA-509 Results After Radical Prostatectomy: Quality-of-Life Outcomes - 26 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2JNCCN 360 - Advanced Skin Cancers - Anti–PD-L1 Refractory Melanoma: Combining Tyrosine Kinase and PD-1 Inhibitors - 27 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0JNCCN 360 - MM - Novel Treatments for Multiple Myeloma May Emerge From Ephrin B2 Research - 27 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1JNCCN 360 - Breast - Copper-Related Genes and Response to Trastuzumab in HER2-Positive Disease - 28 day(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Posted: Thursday, April 4, 2024 The U.S. Food and Drug Administration (FDA) first approved nivolumab (Opdivo) to treat metastatic squamous non–small cell lung cancer (NSCLC) in 2015. Nivolumab is a fully human immunoglobulin G4 (IgG4) monoclonal antibody against PD-1. This made it the first immunotherapy to be approved for the treatment of any type of lung cancer, and it brought about a paradigm shift in the management of advanced NSCLC. It has not only significantly improved the prognosis of patients
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3JNCCN 360 - MM - Relationship Between Age and Outcomes in Multiple Myeloma: A View From Latin America - 1 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
The August issue of @JNCCN is now available online! Featured: @NCCN Guidelines on Adolescent and Young Adult (#AYA) Oncology, insights into recent updates to #NCCNGuidelines for #Survivorship, and more! https://t.co/8t8aPaSww2 #AYAcsm #survonc https://t.co/WiN2kzpsqA